Welcome to the new faculty member, Dr. Satish Chitneni, PhD (Radiology). Dr. Chitneni’s research interest include development and validation of novel radiopharmaceuticals for targeted molecular imaging of cancer and for imaging neuroreceptors and enzyme systems in the brain with positron emission tomography (PET). Specifically, current research efforts are directed toward developing PET imaging agents for the recently discovered, cancer-associated IDH gene mutations in brain tumors, and the use of PET for monitoring treatment response in small animal models. General research interests also include translation of new, pre-clinically validated radiotracers for human use under appropriate FDA regulatory mechanisms.
